< Back to latest news & events

Event

Alt Protein Conference – Transforming the Future of Food

September 2020

Event date: 2nd September 2020

HGF is the Intellectual Property Partner for the Alt Protein Conference on 2nd-3rd September 2020.

Alt Protein Conference 2020 will focus on the new wave of future food companies transforming the business of tomorrow.

The conference will be held over two days virtually and the attendees will be able to learn about the latest business trends and best practices to transform the future of food with cellular agriculture and plant-based alternative proteins.

HGF Partner Kerry Rees will be hosting a session on 2nd September:

Intellectual Property and the Alt Protein market: Using IP to attract investment

IP is a key asset for technology-driven companies and is used to attract funding from investors at all stages of a company’s development. Companies that can demonstrate an intelligent IP strategy are more likely to gain investor confidence, whereas any weakness in an IP portfolio can reduce company value and undermine a funding deal. The presentation will discuss key aspects in the development of investment confident IP strategy.

HGF Partner Marie McMorrow and Patent Director Dr Jennifer Bailey will also be attending the event.

Latest updates

Exam Success!

HGF are delighted to announce success for many of our colleagues in the recent exams on becoming qualified attorneys and would like to congratulate them on this fantastic achievement. Martyn …

Read article

In2ScienceUK continues to promote diversity and inclusion in STEM and IP with its award winning programme

HGF are proud sponsors of In2ScienceUK, a charity that gives young people from low-income backgrounds the opportunity to gain essential insights into science, technology, engineering, and mathematics (STEM) careers with …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article